col0,col1,col2,col3,col4,col5
tazarotene,351.1293,keratolytic,Retinoic acid receptor alpha,acne,medication
erlotinib,393.169,protein kinase inhibitor,Epidermal growth factor receptor,pancreatic cancer,medication
tazarotene,351.1293,keratolytic,Retinoic acid receptor alpha,acne,chemical compound
erlotinib,393.169,protein kinase inhibitor,Epidermal growth factor receptor,pancreatic cancer,chemical compound
